SP
BravenNow
Alignment healthcare COO Burzacchi sells $274k in stock
| USA | economy | ✓ Verified - investing.com

Alignment healthcare COO Burzacchi sells $274k in stock

Entity Intersection Graph

No entity connections available yet for this article.

}
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold slides on bets for higher interest rates for longer amid raging Iran war Oil reverses course, but Brent still hovering near highest level since July 2022 Stocks end lower in choppy session after Netanyahu says Iran can’t enrich uranium Ed Yardeni sees risk to his bullish gold target as prices lag expectations (South Africa Philippines Nigeria) Alignment healthcare COO Burzacchi sells $274k in stock By Insider Trading Published 03/19/2026, 06:55 PM Alignment healthcare COO Burzacchi sells $274k in stock 0 ALHC -0.16% Alignment Healthcare (NASDAQ:ALHC) Chief Operating Officer, Sebastian Burzacchi, sold 15,361 shares of common stock on March 18, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted-average price of $17.84, for a total transaction value of $274,040. The prices obtained for the shares sold ranged from $17.40 to $18.24. Following the transaction, Burzacchi directly owns 258,630 shares of Alignment Healthcare.The stock currently trades at $18.16, with InvestingPro analysis suggesting the company is undervalued at current levels. The healthcare company posted impressive 46% revenue growth and earned a "GREAT" financial health score. InvestingPro Tips highlight that analysts predict profitability this year, with net income expected to grow—part of 8+ additional tips available to subscribers. The sale was to cover tax withholding obligations related to the vesting of restricted stock units, and not a discretionary trade. In other recent news, Alignment Healthcare reported significant growth in its fourth-quarter results. The company achieved approximately 25% year-over-year membership growth and a 44.4% increase in revenue, surpassing expectations. The medical benefit ratio was reported at 87.7%, with an improvement in the selling, general, and administrative expense ratio to 9.7%. Following these results, Raymond James reiterated a Stro...
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine